China Translational Regenerative Medicine Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Translational Regenerative Medicine industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Pharmicell

    • AxoGen

    • MEDIPOST

    • Athersys

    • Regenerys

    • Takeda Pharmaceutical

    • Avita Medical

    • Vericel

    • NuVasive

    • Osiris Therapeutics

    • Organogenesis Holdings

    By Type:

    • Gene Therapy

    • Tissue Engineering

    • Stem Cell Therapy

    By Application:

    • Other

    • Tissue Engineering Therapy

    • Wound Healing

    • Cartilage Repair

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Translational Regenerative Medicine Market Overview 2018-2029

    • 1.1 China Translational Regenerative Medicine Industry Development Overview

    • 1.2 China Translational Regenerative Medicine Industry Development History

    • 1.3 China Translational Regenerative Medicine Industry Market Size (2018-2029)

    • 1.4 China Translational Regenerative Medicine Market Analysis by Type from Production Side

      • 1.4.1 China Translational Regenerative Medicine Production Volume, Production Value and Growth Rate of Gene Therapy (2018-2029)

      • 1.4.2 China Translational Regenerative Medicine Production Volume, Production Value and Growth Rate of Tissue Engineering (2018-2029)

      • 1.4.3 China Translational Regenerative Medicine Production Volume, Production Value and Growth Rate of Stem Cell Therapy (2018-2029)

    • 1.5 China Translational Regenerative Medicine Market Analysis by Application from Consumption End

      • 1.5.1 China Translational Regenerative Medicine Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

      • 1.5.2 China Translational Regenerative Medicine Sales Volume, Sales Value and Growth Rate of Tissue Engineering Therapy (2018-2029)

      • 1.5.3 China Translational Regenerative Medicine Sales Volume, Sales Value and Growth Rate of Wound Healing (2018-2029)

      • 1.5.4 China Translational Regenerative Medicine Sales Volume, Sales Value and Growth Rate of Cartilage Repair (2018-2029)

    • 1.6 China Translational Regenerative Medicine Market Analysis by Region

      • 1.6.1 North China Translational Regenerative Medicine Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Translational Regenerative Medicine Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Translational Regenerative Medicine Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Translational Regenerative Medicine Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Translational Regenerative Medicine Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Translational Regenerative Medicine Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Translational Regenerative Medicine Market Size and Growth Rate from 2018-2029

    Chapter 2 China Translational Regenerative Medicine Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Translational Regenerative Medicine Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Translational Regenerative Medicine Market Status and Competition Analysis in 2023

      • 2.2.3 China Translational Regenerative Medicine Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Translational Regenerative Medicine Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Translational Regenerative Medicine Industry Development

    Chapter 3 Translational Regenerative MedicineIndustry Chain Analysis

    • 3.1 Translational Regenerative Medicine Industry Chain

    • 3.2 Translational Regenerative Medicine Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Translational Regenerative Medicine Market

    • 3.3 Translational Regenerative Medicine Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Translational Regenerative Medicine Market

    Chapter 4 China Translational Regenerative Medicine Market, by Type

    • 4.1 China Translational Regenerative Medicine Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Translational Regenerative Medicine Total Production Volume and Growth Rate from Production Side

    • 4.5 China Translational Regenerative Medicine Production Volume and Growth Rate, by Type

      • 4.5.1 China Translational Regenerative Medicine Production Volume and Growth Rate of Gene Therapy

      • 4.5.2 China Translational Regenerative Medicine Production Volume and Growth Rate of Tissue Engineering

      • 4.5.3 China Translational Regenerative Medicine Production Volume and Growth Rate of Stem Cell Therapy

    Chapter 5 China Translational Regenerative Medicine Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Translational Regenerative Medicine Total Market Size and Growth Rate from Consumption End

    • 5.5 China Translational Regenerative Medicine Market Size and Growth Rate, by Application

      • 5.5.1 China Translational Regenerative Medicine Market Size and Growth Rate of Other

      • 5.5.2 China Translational Regenerative Medicine Market Size and Growth Rate of Tissue Engineering Therapy

      • 5.5.3 China Translational Regenerative Medicine Market Size and Growth Rate of Wound Healing

      • 5.5.4 China Translational Regenerative Medicine Market Size and Growth Rate of Cartilage Repair

    Chapter 6 China Translational Regenerative Medicine Market, by Region

    • 6.1 China Translational Regenerative Medicine Production Volume and Production Value, by Region

    • 6.2 China Translational Regenerative Medicine Sales Volume and Sales Value, by Region

    Chapter 7 North China Translational Regenerative Medicine Market Analysis

    • 7.1 North China Translational Regenerative Medicine Market, by Type

    • 7.2 North China Translational Regenerative Medicine Market, by Application

    Chapter 8 Central China Translational Regenerative Medicine Market Analysis

    • 8.1 Central China Translational Regenerative Medicine Market, by Type

    • 8.2 Central China Translational Regenerative Medicine Market, by Application

    Chapter 9 South China Translational Regenerative Medicine Market Analysis

    • 9.1 South China Translational Regenerative Medicine Market, by Type

    • 9.2 South China Translational Regenerative Medicine Market, by Application

    Chapter 10 East China Translational Regenerative Medicine Market Analysis

    • 10.1 East China Translational Regenerative Medicine Market, by Type

    • 10.2 East China Translational Regenerative Medicine Market, by Application

    Chapter 11 Northeast China Translational Regenerative Medicine Market Analysis

    • 11.1 Northeast China Translational Regenerative Medicine Market, by Type

    • 11.2 Northeast China Translational Regenerative Medicine Market, by Application

    Chapter 12 Southwest China Translational Regenerative Medicine Market Analysis

    • 12.1 Southwest China Translational Regenerative Medicine Market, by Type

    • 12.2 Southwest China Translational Regenerative Medicine Market, by Application

    Chapter 13 Northwest China Translational Regenerative Medicine Market Analysis

    • 13.1 Northwest China Translational Regenerative Medicine Market, by Type

    • 13.2 Northwest China Translational Regenerative Medicine Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Pharmicell

        • 14.1.1 Pharmicell Company Profile

        • 14.1.2 Pharmicell Translational Regenerative Medicine Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 AxoGen

        • 14.2.1 AxoGen Company Profile

        • 14.2.2 AxoGen Translational Regenerative Medicine Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 MEDIPOST

        • 14.3.1 MEDIPOST Company Profile

        • 14.3.2 MEDIPOST Translational Regenerative Medicine Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Athersys

        • 14.4.1 Athersys Company Profile

        • 14.4.2 Athersys Translational Regenerative Medicine Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Regenerys

        • 14.5.1 Regenerys Company Profile

        • 14.5.2 Regenerys Translational Regenerative Medicine Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Takeda Pharmaceutical

        • 14.6.1 Takeda Pharmaceutical Company Profile

        • 14.6.2 Takeda Pharmaceutical Translational Regenerative Medicine Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Avita Medical

        • 14.7.1 Avita Medical Company Profile

        • 14.7.2 Avita Medical Translational Regenerative Medicine Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Vericel

        • 14.8.1 Vericel Company Profile

        • 14.8.2 Vericel Translational Regenerative Medicine Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 NuVasive

        • 14.9.1 NuVasive Company Profile

        • 14.9.2 NuVasive Translational Regenerative Medicine Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Osiris Therapeutics

        • 14.10.1 Osiris Therapeutics Company Profile

        • 14.10.2 Osiris Therapeutics Translational Regenerative Medicine Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Organogenesis Holdings

        • 14.11.1 Organogenesis Holdings Company Profile

        • 14.11.2 Organogenesis Holdings Translational Regenerative Medicine Market Performance

        • 14.11.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Translational Regenerative Medicine Industry Research Conclusions

    • 15.2 Translational Regenerative Medicine Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Translational Regenerative Medicine Industry Market Size (2018-2029)

    • Figure China Translational Regenerative Medicine Production Volume, Production Value and Growth Rate of Gene Therapy (2018-2029)

    • Figure China Translational Regenerative Medicine Production Volume, Production Value and Growth Rate of Tissue Engineering (2018-2029)

    • Figure China Translational Regenerative Medicine Production Volume, Production Value and Growth Rate of Stem Cell Therapy (2018-2029)

    • Figure China Translational Regenerative Medicine Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

    • Figure China Translational Regenerative Medicine Sales Volume, Sales Value and Growth Rate of Tissue Engineering Therapy (2018-2029)

    • Figure China Translational Regenerative Medicine Sales Volume, Sales Value and Growth Rate of Wound Healing (2018-2029)

    • Figure China Translational Regenerative Medicine Sales Volume, Sales Value and Growth Rate of Cartilage Repair (2018-2029)

    • Figure North China Translational Regenerative Medicine Market Size and Growth Rate from 2018-2029

    • Figure Central China Translational Regenerative Medicine Market Size and Growth Rate from 2018-2029

    • Figure South China Translational Regenerative Medicine Market Size and Growth Rate from 2018-2029

    • Figure East China Translational Regenerative Medicine Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Translational Regenerative Medicine Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Translational Regenerative Medicine Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Translational Regenerative Medicine Market Size and Growth Rate from 2018-2029

    • Figure Translational Regenerative Medicine Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Translational Regenerative Medicine Market Share by Type in 2018

    • Figure China Translational Regenerative Medicine Market Share by Type in 2023

    • Figure China Translational Regenerative Medicine Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Translational Regenerative Medicine Production Volume and Growth Rate of Gene Therapy (2018-2023)

    • Figure China Translational Regenerative Medicine Production Volume and Growth Rate of Tissue Engineering (2018-2023)

    • Figure China Translational Regenerative Medicine Production Volume and Growth Rate of Stem Cell Therapy (2018-2023)

    • Figure China Translational Regenerative Medicine Market Share by Application in 2018

    • Figure China Translational Regenerative Medicine Market Share by Application in 2023

    • Figure China Translational Regenerative Medicine Total Market Size and Growth Rate from Consumption End

    • Figure China Translational Regenerative Medicine Market Size and Growth Rate of Other (2018-2023)

    • Figure China Translational Regenerative Medicine Market Size and Growth Rate of Tissue Engineering Therapy (2018-2023)

    • Figure China Translational Regenerative Medicine Market Size and Growth Rate of Wound Healing (2018-2023)

    • Figure China Translational Regenerative Medicine Market Size and Growth Rate of Cartilage Repair (2018-2023)

    • Table China Translational Regenerative Medicine Production Volume by Region (2018-2023)

    • Table China Translational Regenerative Medicine Production Volume Share by Region (2018-2023)

    • Figure China Translational Regenerative Medicine Production Volume Share by Region (2018-2023)

    • Table China Translational Regenerative Medicine Production Value by Region (2018-2023)

    • Table China Translational Regenerative Medicine Production Value Share by Region (2018-2023)

    • Figure China Translational Regenerative Medicine Production Value Share by Region (2018-2023)

    • Table China Translational Regenerative Medicine Sales Volume by Region (2018-2023)

    • Table China Translational Regenerative Medicine Sales Volume Share by Region (2018-2023)

    • Figure China Translational Regenerative Medicine Sales Volume Share by Region (2018-2023)

    • Table China Translational Regenerative Medicine Sales Value by Region (2018-2023)

    • Table China Translational Regenerative Medicine Sales Value Share by Region (2018-2023)

    • Figure China Translational Regenerative Medicine Sales Value Share by Region (2018-2023)

    • Table North China Translational Regenerative Medicine Production Volume by Type (2018-2023)

    • Table North China Translational Regenerative Medicine Production Volume Share by Type (2018-2023)

    • Figure North China Translational Regenerative Medicine Production Volume Share by Type (2018-2023)

    • Table North China Translational Regenerative Medicine Sales Volume by Application (2018-2023)

    • Table North China Translational Regenerative Medicine Sales Volume Share by Application (2018-2023)

    • Figure North China Translational Regenerative Medicine Sales Volume Share by Application (2018-2023)

    • Table Central China Translational Regenerative Medicine Production Volume by Type (2018-2023)

    • Table Central China Translational Regenerative Medicine Production Volume Share by Type (2018-2023)

    • Figure Central China Translational Regenerative Medicine Production Volume Share by Type (2018-2023)

    • Table Central China Translational Regenerative Medicine Sales Volume by Application (2018-2023)

    • Table Central China Translational Regenerative Medicine Sales Volume Share by Application (2018-2023)

    • Figure Central China Translational Regenerative Medicine Sales Volume Share by Application (2018-2023)

    • Table South China Translational Regenerative Medicine Production Volume by Type (2018-2023)

    • Table South China Translational Regenerative Medicine Production Volume Share by Type (2018-2023)

    • Figure South China Translational Regenerative Medicine Production Volume Share by Type (2018-2023)

    • Table South China Translational Regenerative Medicine Sales Volume by Application (2018-2023)

    • Table South China Translational Regenerative Medicine Sales Volume Share by Application (2018-2023)

    • Figure South China Translational Regenerative Medicine Sales Volume Share by Application (2018-2023)

    • Table East China Translational Regenerative Medicine Production Volume by Type (2018-2023)

    • Table East China Translational Regenerative Medicine Production Volume Share by Type (2018-2023)

    • Figure East China Translational Regenerative Medicine Production Volume Share by Type (2018-2023)

    • Table East China Translational Regenerative Medicine Sales Volume by Application (2018-2023)

    • Table East China Translational Regenerative Medicine Sales Volume Share by Application (2018-2023)

    • Figure East China Translational Regenerative Medicine Sales Volume Share by Application (2018-2023)

    • Table Northeast China Translational Regenerative Medicine Production Volume by Type (2018-2023)

    • Table Northeast China Translational Regenerative Medicine Production Volume Share by Type (2018-2023)

    • Figure Northeast China Translational Regenerative Medicine Production Volume Share by Type (2018-2023)

    • Table Northeast China Translational Regenerative Medicine Sales Volume by Application (2018-2023)

    • Table Northeast China Translational Regenerative Medicine Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Translational Regenerative Medicine Sales Volume Share by Application (2018-2023)

    • Table Southwest China Translational Regenerative Medicine Production Volume by Type (2018-2023)

    • Table Southwest China Translational Regenerative Medicine Production Volume Share by Type (2018-2023)

    • Figure Southwest China Translational Regenerative Medicine Production Volume Share by Type (2018-2023)

    • Table Southwest China Translational Regenerative Medicine Sales Volume by Application (2018-2023)

    • Table Southwest China Translational Regenerative Medicine Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Translational Regenerative Medicine Sales Volume Share by Application (2018-2023)

    • Table Northwest China Translational Regenerative Medicine Production Volume by Type (2018-2023)

    • Table Northwest China Translational Regenerative Medicine Production Volume Share by Type (2018-2023)

    • Figure Northwest China Translational Regenerative Medicine Production Volume Share by Type (2018-2023)

    • Table Northwest China Translational Regenerative Medicine Sales Volume by Application (2018-2023)

    • Table Northwest China Translational Regenerative Medicine Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Translational Regenerative Medicine Sales Volume Share by Application (2018-2023)

    • Table Pharmicell Company Profile

    • Table Pharmicell Translational Regenerative Medicine Revenue, Price and Gross (2018-2023)

    • Table AxoGen Company Profile

    • Table AxoGen Translational Regenerative Medicine Revenue, Price and Gross (2018-2023)

    • Table MEDIPOST Company Profile

    • Table MEDIPOST Translational Regenerative Medicine Revenue, Price and Gross (2018-2023)

    • Table Athersys Company Profile

    • Table Athersys Translational Regenerative Medicine Revenue, Price and Gross (2018-2023)

    • Table Regenerys Company Profile

    • Table Regenerys Translational Regenerative Medicine Revenue, Price and Gross (2018-2023)

    • Table Takeda Pharmaceutical Company Profile

    • Table Takeda Pharmaceutical Translational Regenerative Medicine Revenue, Price and Gross (2018-2023)

    • Table Avita Medical Company Profile

    • Table Avita Medical Translational Regenerative Medicine Revenue, Price and Gross (2018-2023)

    • Table Vericel Company Profile

    • Table Vericel Translational Regenerative Medicine Revenue, Price and Gross (2018-2023)

    • Table NuVasive Company Profile

    • Table NuVasive Translational Regenerative Medicine Revenue, Price and Gross (2018-2023)

    • Table Osiris Therapeutics Company Profile

    • Table Osiris Therapeutics Translational Regenerative Medicine Revenue, Price and Gross (2018-2023)

    • Table Organogenesis Holdings Company Profile

    • Table Organogenesis Holdings Translational Regenerative Medicine Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.